<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Overall survival in acute myeloid leukemia</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Overall survival in acute myeloid leukemia</h1>
<div class="graphic"><div class="figure"><div class="ttl">Overall survival in acute myeloid leukemia</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">This figure illustrates overall survival in adult subjects with acute myeloid leukemia (AML, age range 15 to 86 years, median 52 years), according to the following cytogenetic risk categories: Favorable risk (median survival 7.6 years): t(8;21); inv(16) or t(16;16); del(9q). Intermediate risk (median survival 1.3 years): normal karyotype; -Y; del(5q); loss of 7q; t(9;11); +11; del(11q); abn(12p); +13; del(20q); +21. Adverse risk (median survival 0.5 years): complex karyotype (≥3 abnormalities); inv(3) or t(3;3); t(6;9); t(6;11); -7; +8 (sole abnormality); +8 with one other abnormality other than t(8;21), t(9;11), inv(16), or t(16;16); t(11;19)(q23;p13.1).</div><div class="graphic_reference">Data from Byrd, JC, et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: Results from Cancer and Leukemia Group B (CALGB 8641). Blood 2002; 100:4325.</div><div id="graphicVersion">Graphic 65190 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
